## **Core Concept**
Phosphofructokinase-1 (PFK-1) is a key regulatory enzyme in the glycolytic pathway, catalyzing the conversion of fructose-6-phosphate into fructose-1,6-bisphosphate. This step is one of the rate-limiting steps of glycolysis. PFK-1 is subject to allosteric control by various metabolites, which reflect the energy status of the cell.

## **Why the Correct Answer is Right**
The correct answer, **AMP**, acts as an allosteric activator of phosphofructokinase-1. When cellular energy levels are low, as indicated by a high AMP:ATP ratio, AMP binds to PFK-1, enhancing its activity. This activation promotes glycolysis to increase ATP production. AMP serves as a signal of low energy status within the cell, thereby appropriately regulating glycolytic flux.

## **Why Each Wrong Option is Incorrect**
- **Option A: ATP** - ATP is an allosteric inhibitor of phosphofructokinase-1. When ATP levels are high, indicating a high energy status within the cell, ATP binds to PFK-1, reducing its activity and thereby inhibiting glycolysis.
- **Option B: Citrate** - Citrate is also an allosteric inhibitor of phosphofructokinase-1. High levels of citrate indicate a high energy status and sufficient biosynthetic precursors, leading to inhibition of glycolysis and promotion of gluconeogenesis and fatty acid synthesis.
- **Option D: NADH** - While NADH is a product of glycolysis (and the citric acid cycle) and can indicate a high energy status within the cell, it is not a direct allosteric regulator of phosphofructokinase-1 like AMP, ATP, or citrate.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that phosphofructokinase-1 is a critical regulatory enzyme in glycolysis, and its activity is finely tuned by the cell's energy status through allosteric effectors. This regulation ensures that glycolytic flux is adjusted according to the cell's needs for energy production.

## **Correct Answer: C. AMP**